SMYD1
Histone-lysine N-methyltransferase SMYD1
Also known as: BOP, KMT3D, SMYD1_HUMAN, ZMYND22
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NB12
- Gene
- SMYD1
- Ensembl
- ENSG00000115593
- Chromosome
- 2
- Canonical length
- 490 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable several functions, including histone H3K4 trimethyltransferase activity; transcription corepressor activity; and zinc ion binding activity. Involved in positive regulation of myoblast differentiation and positive regulation of myotube differentiation. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
490 residues, UniProt reviewed canonical sequence.
>Q8NB12|SMYD1
1 MTIGRMENVE VFTAEGKGRG LKATKEFWAA DIIFAERAYS AVVFDSLVNF VCHTCFKRQE
61 KLHRCGQCKF AHYCDRTCQK DAWLNHKNEC SAIKRYGKVP NENIRLAARI MWRVEREGTG
121 LTEGCLVSVD DLQNHVEHFG EEEQKDLRVD VDTFLQYWPP QSQQFSMQYI SHIFGVINCN
181 GFTLSDQRGL QAVGVGIFPN LGLVNHDCWP NCTVIFNNGN HEAVKSMFHT QMRIELRALG
241 KISEGEELTV SYIDFLNVSE ERKRQLKKQY YFDCTCEHCQ KKLKDDLFLG VKDNPKPSQE
301 VVKEMIQFSK DTLEKIDKAR SEGLYHEVVK LCRECLEKQE PVFADTNIYM LRMLSIVSEV
361 LSYLQAFEEA SFYARRMVDG YMKLYHPNNA QLGMAVMRAG LTNWHAGNIE VGHGMICKAY
421 AILLVTHGPS HPITKDLEAM RVQTEMELRM FRQNEFMYYK MREAALNNQP MQVMAEPSNE
481 PSPALFHKKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMYD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 462 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 462 nTPM
- tongue: 281 nTPM
- heart muscle: 153 nTPM
- smooth muscle: 26 nTPM
- colon: 17 nTPM
- small intestine: 7.2 nTPM
Single-cell type
- myonuclei: 393 nCPM
- cardiomyocytes: 351 nCPM
- thymic myoid cells: 112 nCPM
- breast myoepithelial cells: 30 nCPM
- epicardial cells: 11 nCPM
- adipocytes: 4.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 8.5 nTPM
- white matter: 1.7 nTPM
- pons: 0.5 nTPM
- amygdala: 0.4 nTPM
- basal ganglia: 0.4 nTPM
- cerebellum: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- heart development
- methylation
- positive regulation of myoblast differentiation
- positive regulation of myotube differentiation
- skeletal muscle cell differentiation
Molecular functions
- DNA binding
- histone H3K4 trimethyltransferase activity
- transcription corepressor activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMYD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMYD1 as an antibody target. Whether an autoantibody or antibody against SMYD1 could matter depends on whether native SMYD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMYD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SMYD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...